Literature DB >> 23549961

Successful implantation of autologous muscle-derived stem cells in treatment of faecal incontinence due to external sphincter rupture.

Michal Romaniszyn, Romaniszyn Michal, Natalia Rozwadowska, Rozwadowska Natalia, Marcin Nowak, Nowak Marcin, Agnieszka Malcher, Malcher Agnieszka, Tomasz Kolanowski, Kolanowski Tomasz, Piotr Walega, Walega Piotr, Piotr Richter, Richter Piotr, Maciej Kurpisz, Kurpisz Maciej.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23549961      PMCID: PMC3712182          DOI: 10.1007/s00384-013-1692-y

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


× No keyword cloud information.
Dear Editor: The most common pathological mechanism of faecal incontinence is the insufficiency of the external anal sphincter (EAS) caused by neurological or myogenic dysfunction. The myogenic mechanism of EAS insufficiency is usually due to direct mechanical damage during childbirth, trauma or surgery in anorectal region, whereas neurological aetiology involves either spinal or peripheral nerves disruption—in most cases the pudendal nerve. Unfortunately, coincidence of sphincter rupture with damage to pudendal nerves is quite common. Each skeletal muscle, including EAS, has the ability to regenerate to some degree and repair sustained damage. In response to injury and/or muscle damage, so-called satellite cells are activated and become myoblasts—capable of intense proliferation. Myoblasts then differentiate and fuse together to form new muscle fibres and connect with existing ones, adding new portions of contractile tissue to existing motoric units [1]. Attempts of autotransplantation of myoblasts into damaged skeletal muscle were already made in animal models of muscular dystrophy, post-infarction myocardial dysfunction and urethral sphincter insufficiency [2]. The results showed that the transplanted myoblasts differentiate into muscle fibres, connect with host motoric units, increase the amount of contractile elements in the muscle and improve its contractile activity. In 2001, Menasche et al. first transplanted autologous myoblasts into the post-infarction myocardial scar in human patients with cardiac failure, with significant improvements in contractile function and clinical condition [3]. In Poland, the method of treating post-infarction heart failure was performed for the first time a year later, with similar results [4]. Based on those encouraging results, a pioneer experimental study was designed in attempt to enhance the function of external anal sphincter using injections of autologous muscle-derived stem cells. The study is designed as a prospective experimental study. It is being conducted by two cooperating research centres—the 3rd Department of General Surgery, Jagiellonian University in Cracow and the Department of Reproductive Biology and Stem Cells, Institute of Human Genetics, Polish Academy of Sciences in Poznan. We would like to present a case of the representative patient enrolled to our study. A 20-year old male with faecal incontinence due to an old external anal sphincter rupture in a road accident was enrolled to the study. Sphincter rupture had been repaired surgically right after the accident (with an end-to-end sphincteroplasty). The patient underwent 6 months of biofeedback training after the wounds were healed. At the time of enrolment, he still complained of gas and loose stool incontinence, daily soiling, with necessity to wear pads. Endoanal ultrasound showed a 8–10-mm scar on the left circumference of internal and external sphincter muscle, where anal canal was ruptured during the accident, and surgically repaired afterwards. Anorectal manometry showed decreased both mean resting and maximum squeeze pressure, with short high pressure zone length. Endoanal surface electromyography was performed using a 48-channel, 3-ring endoanal probe according to routine protocol. Mean amplitude and frequency of the signal from each of 16 electrodes (corresponding to 16 cut-outs of external sphincter circumference) were assessed, in each of the three rings (a total of 48 signals in each acquisition). In the signal analysis, there was an area with no electrical activity present—the area corresponded to scar tissue—as it contained mostly fibrous tissue with potentially very few myocytes, it was unable to conduct the motoric units’ action potentials (MUAPs), hence the lack of electrical activity in this area. In Faecal Incontinence Severity Index (FISI) questionnaire the patient scored 30 points. In local anaesthesia, a 1-cm3 sample of lateral head of quadriceps muscle of the thigh was harvested. There were no complications of this procedure. The tissue fragment was mechanically dissected and subjected to digestion with 0.02 % collagenase solution (Sigma). The obtained cell suspension was filtered, centrifuged and plated on gelatine-covered culture dish. The myoblasts were cultured to 70 % confluence and passaged every 4–5 days while the medium was replaced every other day. The myoblasts were cultured for 4.5 weeks. To confirm myogenic properties of obtained cells, their differentiation potential was also assessed. The prepared myoblasts population showed 6.44 % of necrotic cells whereas we did not find any cells with apoptotic characteristics (<0.5 %). After 30 days of in vitro culture, about 6 × 108 myoblasts were prepared for the transplantation procedure. After preparation of the site, the suspension of isolated myogenic stem cells was then administered into the external anal sphincter under direct visual and ultrasonographical guidance. Total volume of the suspension (3 cm3) was divided into three 1-cm3 portions: 1 cm3 was injected on both sides of the muscle scar, one was applied on the remaining circumference of external sphincter muscle ring (several injections 1 cm apart), the last portion was injected directly into the scar, so that the bolus of injected fluid had direct contact with healthy muscle tissue, creating a “bridge” between muscle ends, across the scar. The procedure was performed without any complications, and the patient went home the same day. The patient was scheduled for follow-up visits in 6-week intervals, each of which consisted of general examination, FISI questionnaire, manometry, EMG and ultrasound examinations. Regarding the continence score, there was almost no improvement after 6 weeks, but during the following 6 weeks, patient reported gradual improvement. This correlated with increased anorectal squeeze pressures in manometry. EMG showed MUAPs gradually appearing in the scar area, where there was no visible electrical activity before implantation. Additionally, in the follow-up, overall mean and median frequency of signal was lower than before implantation—meaning that the quantity of synchronous and properly propagating MUAPs was significantly increased in the course of a total of 12 months of observation. After completion of the observation, the patient was still incontinent for flatus, but did not report any soiling nor stool incontinence, and was generally satisfied with the results of the experiment. To sum up, presented case of the enrolled patient provided very encouraging results. The patient not only improved clinically, in terms of subjective assessment of daily stool and flatus continence—which alone might be considered a placebo effect, but also in objective functional assessment, with significant increase in anorectal manometry. The EMG analysis was particularly interesting, as it showed action potentials in regions previously lacking of conductive and contractile capabilities, which may be a “proof of concept” that implanted myoblasts not only developed into myocytes, but were able to “plug-in” to existing motoric units, creating more muscle tissue at individual motoneurons’ disposal. A significant difference in mean and median frequency of electrical activity of the muscle (meaning a change in signal-to-noise ratio in favour of coordinated electrical action potentials) may also be a proof that efficiency of motoric units of the external anal muscle was significantly improved by autologous stem cells implantation. This result must be taken as very encouraging in the light of further conducted phase I/II clinical trial.
  4 in total

1.  [Autologous skeletal myoblast transplantation for cardiac insufficiency. First clinical case].

Authors:  P Menasché; A Hagège; M Scorsin; B Pouzet; M Desnos; D Duboc; K Schwartz; J T Vilquin; J P Marolleau
Journal:  Arch Mal Coeur Vaiss       Date:  2001-03

2.  [Myoblast transplantation in the treatment of post-infarction heart failure].

Authors:  Tomasz Simniak; Ryszard Kalawski; Dorota Fiszer; Aleksandra Klimowicz; Maciej Kurpisz
Journal:  Kardiol Pol       Date:  2002-10       Impact factor: 3.108

3.  On the regenerative capacity of human skeletal muscle.

Authors:  Anton Wernig; Ralf Schäfer; Ulrich Knauf; Rustam R Mundegar; Margit Zweyer; Oliver Högemeier; Uwe M Martens; Stefan Zimmermann
Journal:  Artif Organs       Date:  2005-03       Impact factor: 3.094

4.  Contribution of human muscle-derived cells to skeletal muscle regeneration in dystrophic host mice.

Authors:  Jinhong Meng; Carl F Adkin; Shi-wen Xu; Francesco Muntoni; Jennifer E Morgan
Journal:  PLoS One       Date:  2011-03-09       Impact factor: 3.240

  4 in total
  6 in total

Review 1.  Faecal incontinence: Current knowledges and perspectives.

Authors:  Alban Benezech; Michel Bouvier; Véronique Vitton
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 2.  Regenerative medicine provides alternative strategies for the treatment of anal incontinence.

Authors:  Søren Gräs; Cæcilie Krogsgaard Tolstrup; Gunnar Lose
Journal:  Int Urogynecol J       Date:  2016-06-16       Impact factor: 2.894

3.  Local injection of bone marrow progenitor cells for the treatment of anal sphincter injury: in-vitro expanded versus minimally-manipulated cells.

Authors:  Benedetta Mazzanti; Bruno Lorenzi; Annalisa Borghini; Margherita Boieri; Lara Ballerini; Riccardo Saccardi; Elisabetta Weber; Federica Pessina
Journal:  Stem Cell Res Ther       Date:  2016-06-21       Impact factor: 6.832

4.  Treatment of faecal incontinence using allogeneic-adipose-derived mesenchymal stem cells: a study protocol for a pilot randomised controlled trial.

Authors:  Eun Jung Park; Jeonghyun Kang; Seung Hyuk Baik
Journal:  BMJ Open       Date:  2016-02-17       Impact factor: 2.692

Review 5.  Stem cell therapy for faecal incontinence: Current state and future perspectives.

Authors:  Jacobo Trébol; Ana Carabias-Orgaz; Mariano García-Arranz; Damián García-Olmo
Journal:  World J Stem Cells       Date:  2018-07-26       Impact factor: 5.326

6.  Chromatin and transcriptome changes in human myoblasts show spatio-temporal correlations and demonstrate DPP4 inhibition in differentiated myotubes.

Authors:  Tomasz J Kolanowski; Natalia Rozwadowska; Agnieszka Zimna; Magdalena Nowaczyk; Marcin Siatkowski; Wojciech Łabędź; Ewa Wiland; Jacek Gapiński; Stefan Jurga; Maciej Kurpisz
Journal:  Sci Rep       Date:  2020-08-31       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.